Clinical Trial Update: Probiotics in Infants With Cyanotic Congenital Heart Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating the use of probiotics in infants with cyanotic congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cyanotic Congenital Heart Disease

Snippet

Sponsor: University of California, Davis | Conditions: Cyanotic Congenital Heart Disease | NA | Status: COMPLETED